Neal R. Cutler is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley. John J. Sramek is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley.

• Partial table of contents: OVERVIEW OF PHARMACODYNAMICS. Basic Pharmacodynamic Concepts and Models (R. Wills). Factors Influencing Variability in Kinetics and Dynamics (P. Narang& R. Li). General Perspectives on the Role of Metabolite in Pharmacokineticsand Pharmacodynamics (R. Seifert). Regulatory Perspective: The Role of Pharmacokinetics andPharmacodynamics (L. Lesko & R. Williams). APPLICATION OF PHARMACODYNAMICS IN SELECTED THERAPEUTICDOMAINS. Theoretical Models for Developing Anxiolytics (P. Nickell & T.Uhde). Pharmacodynamics of Antipsychotic Drugs in Schizophrenia (J. Sramek& G. Simpson). Antihypertensive Drugs (L. Prisant & A. Carr). Pharmacodynamics of Antineoplastic Agents (G. Rosner & M.Ratain). Virology and Antiviral Drug Development (M. Amantea, et al.). FRONTIERS IN PHARMACODYNAMICS: INSIGHT FROM MOLECULARAPPROACHES. Muscarinic Receptors: Pharmacological Subtypes, Structure, Functionand Regulation (L. Mei, et al.). Serotonin Receptor Subtypes (D. Pritchett). Index.

Neal R. Cutler is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley. John J. Sramek is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley.

• Partial table of contents: OVERVIEW OF PHARMACODYNAMICS. Basic Pharmacodynamic Concepts and Models (R. Wills). Factors Influencing Variability in Kinetics and Dynamics (P. Narang& R. Li). General Perspectives on the Role of Metabolite in Pharmacokineticsand Pharmacodynamics (R. Seifert). Regulatory Perspective: The Role of Pharmacokinetics andPharmacodynamics (L. Lesko & R. Williams). APPLICATION OF PHARMACODYNAMICS IN SELECTED THERAPEUTICDOMAINS. Theoretical Models for Developing Anxiolytics (P. Nickell & T.Uhde). Pharmacodynamics of Antipsychotic Drugs in Schizophrenia (J. Sramek& G. Simpson). Antihypertensive Drugs (L. Prisant & A. Carr). Pharmacodynamics of Antineoplastic Agents (G. Rosner & M.Ratain). Virology and Antiviral Drug Development (M. Amantea, et al.). FRONTIERS IN PHARMACODYNAMICS: INSIGHT FROM MOLECULARAPPROACHES. Muscarinic Receptors: Pharmacological Subtypes, Structure, Functionand Regulation (L. Mei, et al.). Serotonin Receptor Subtypes (D. Pritchett). Index.

Neal R. Cutler is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley. John J. Sramek is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley.

• Partial table of contents: OVERVIEW OF PHARMACODYNAMICS. Basic Pharmacodynamic Concepts and Models (R. Wills). Factors Influencing Variability in Kinetics and Dynamics (P. Narang& R. Li). General Perspectives on the Role of Metabolite in Pharmacokineticsand Pharmacodynamics (R. Seifert). Regulatory Perspective: The Role of Pharmacokinetics andPharmacodynamics (L. Lesko & R. Williams). APPLICATION OF PHARMACODYNAMICS IN SELECTED THERAPEUTICDOMAINS. Theoretical Models for Developing Anxiolytics (P. Nickell & T.Uhde). Pharmacodynamics of Antipsychotic Drugs in Schizophrenia (J. Sramek& G. Simpson). Antihypertensive Drugs (L. Prisant & A. Carr). Pharmacodynamics of Antineoplastic Agents (G. Rosner & M.Ratain). Virology and Antiviral Drug Development (M. Amantea, et al.). FRONTIERS IN PHARMACODYNAMICS: INSIGHT FROM MOLECULARAPPROACHES. Muscarinic Receptors: Pharmacological Subtypes, Structure, Functionand Regulation (L. Mei, et al.). Serotonin Receptor Subtypes (D. Pritchett). Index.